PAULA BERGAMINI: Open Payments
NPI 1225099112 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 17 payments from 13 companies in 2025. Trend: 2023 $27 · 2024 $159 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $52 |
| ABBVIE INC. | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Medtronic, Inc. | 2 | $39 |
| Almatica Pharma LLC | 1 | $28 |
| Lilly USA, LLC | 1 | $27 |
| Bausch Health US, LLC | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Agios Pharmaceuticals, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: AIRSUPRA, JARDIANCE, INCEPTIV, QULIPTA, TERIPARATIDE, MOUNJARO, APLENZIN, RECORLEV.
Industry payments across VA — which companies pay providers there.
